APA (7th ed.) Citation

Tingting Fang, Congcong Ma, Zhanming Zhang, Luning Sun, & Ningning Zheng. (2023). Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Tingting Fang, Congcong Ma, Zhanming Zhang, Luning Sun, and Ningning Zheng. Roxadustat, a HIF-PHD Inhibitor with Exploitable Potential on Diabetes-related Complications. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Tingting Fang, et al. Roxadustat, a HIF-PHD Inhibitor with Exploitable Potential on Diabetes-related Complications. Frontiers Media S.A., 2023.